Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tema Cardiovascular and Metabolic ETF (HRTS)

Tema Cardiovascular and Metabolic ETF (HRTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Tema ETFs
  • Assets Under Management 89,763,600
  • Shares Outstanding, K 2,540
  • 60-Month Beta N/A
Trade HRTS with:
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.75%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.00 +10.44%
on 08/07/24
35.52 -0.51%
on 08/29/24
+1.27 (+3.73%)
since 07/30/24
3-Month
31.66 +11.62%
on 05/31/24
36.03 -1.92%
on 07/16/24
+3.66 (+11.55%)
since 05/30/24

Most Recent Stories

More News
Not Sure Which Weight Loss Stock to Buy? Invest in This ETF

Many healthcare companies have been eagerly developing new weight loss drugs in an effort to cash in ...

LLY : 960.02 (+2.11%)
VKTX : 64.12 (+2.35%)
HRTS : 35.34 (+0.40%)
Don’t Know Which Weight-Loss Stock Will Be the Biggest Winner? Invest in This ETF Instead

There’s a lot of excitement in the weight-loss industry these days. Between Ozempic, Wegovy, Mounjaro, ...

HRTS : 35.34 (+0.40%)
LLY : 960.02 (+2.11%)
NVO : 139.16 (+1.19%)

Fund Summary

The Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital by investing in companies leading the fight against diabetes, obesity and cardiovascular diseases.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 35.82
2nd Resistance Point 35.61
1st Resistance Point 35.47
Last Price 35.34
1st Support Level 35.12
2nd Support Level 34.91
3rd Support Level 34.77

See More

52-Week High 36.03
Last Price 35.34
Fibonacci 61.8% 32.30
Fibonacci 50% 31.14
Fibonacci 38.2% 29.99
52-Week Low 26.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar